Download presentation

Presentation is loading. Please wait.

Published byAlec Runnells Modified over 2 years ago

1
By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami

2
OUTLINE What is Survival Analysis? Censored Data Kaplan-Meier Estimator Log-Rank Test Cox Regression Model

3
WHAT IS SURVIVAL ANALYSIS? Branch of statistics that focuses on time-to- event data and their analysis. Survival data deal with time until occurrence of any well-defined event. The outcome variable examined is the survival time (the time until the occurrence of the event). Special because it can incorporate information about censored data into analysis.

4
OBJECTIVES OF SURVIVAL ANALYSIS? Estimate probability that an individual surpasses some time-to-event for a group of individuals. – Ex) probability of surviving longer than two months until second heart attach for a group of MI patients. Compare time-to-event between two or more groups. – Ex) Treatment vs placebo patients for a randomized controlled trial. Assess the relationship of covariates to time-to- event. – Ex) Does weight, BP, sugar, height influence the survival time for a group of patients?

5
SITUATIONS WHEN WE CAN USE SURVIVAL ANALYSIS We can use survival analysis when you wish to analyze survival times or time-to-event times Time-to-Event include: – Time to death – Time until response to a treatment – Time until relapse of a disease – Time until cancellation of service – Time until resumption of smoking by someone who had quit – Time until certain percentage of weight loss

6
MORE EXAMPLES Suppose you wish to analyze the time it takes for a student to complete a series of classes. – Response /Status Variable: Time it takes to complete, status – Predictor Variables:Age, Gender, Race, GPA Suppose you wish to analyze the time between admittance to the hospital until death for a lung cancer patient. – Response/Status Variables : Length-of-Follow up, status – Predictor Variables:Age, Gender, Race, White Blood Counts, Tumor Type, Treatment Type, Cancerous Mass Size

7
MORE EXAMPLES Suppose you are interested in comparing the time until you lose 10% body weight on one of two exercise programs. – Response/Status Variables: Time it Takes, Status – Predictor Variables:Age, Gender, Starting Weight, BP, BMI, Exercise Program Suppose you are interested in the time it takes before one sees results for a certain treatment. – Response/Status Variables: Time it Takes, Status – Predictor Variables:Age, Gender, Type of Treatment, Weight, Height, exercise (Y/N), healthy eating (Y/N)

8
MORE EXAMPLES Suppose you wish to compare the time it takes before you cancel your cable TV service when you use two different cable providers. – Response/Status Variables: Time it Takes, Status – Predictor Variables:Age, Gender, Race, Cable Provider, Average Income, Average number of complaints per month

9
DATA Survival data can be one of two types: – Complete Data – Censored Data Complete data – the value of each sample unit is observed or known. Censored data – the time to the event of interest may not be observed or the exact time is not known. We distinguish complete data from censored data by adding a + to any values that are censored. (i.e. 4+)

10
CENSORED DATA Censored data can occur when: – The event of interest is death, but the patient is still alive at the time of analysis. – The individual was lost to follow-up without having the event of interest. – The event of interest is death by cancer but the patient died of an unrelated cause, such as a car accident. – The patient is dropped from the study without having experienced the event of interest due to a protocol violation. Even if an observation is censored we will still include it in our analysis.

11

12
FUNCTION DESCRIBING SURVIVAL TIMES

13
SURVIVAL FUNCTION

14

15
KAPLAN-MEIER ESTIMATOR

16
KAPLAN-MEIER (KM) ESTIMATOR

17
KAPLAN-MEIER ESTIMATOR

18
HOW TO CALCULATE THE KM ESTIMATOR

19
SURVIVAL CURVE

20
EXAMPLE DATA The MYEL Data Set: Myelomatosis Patients The MYEL data set contains survival times for 25 patients diagnosed with myelomatosis (Peto et al., 1977). The patients were randomly assigned to two drug treatments. The variables are as follows: DUR is the time in days from the point of randomization to either death or censoring STATUS has a value of 1 if dead and a value of 0 if alive. » This tells is that the censored value will be 0 if the patient is alive and 1 or uncensored if they are dead TREAT specifies a value of 1 or 2 that corresponds to the two treatments. RENAL has a value of 1 if renal functioning was normal

21
WHAT DO THE DATA LOOK LIKE? Snapshot of the data durstatustreatrenal

22
KM EXAMPLE USING SPSS Analyze > Survival > Kaplan Meier Time: Dur Status: status(1) – Here define 1 since it the value indicating event has occurred (i.e. death) Options: Check off survival plot

23
OUTPUT

24

25

26
LOG-RANK TEST Comparing the survival curves of two treatment groups

27
LOG-RANK TEST Use the Log-Rank Test to compare the survival functions of two samples. H 0 : The two survival functions are the equivalent H a : The two survival functions are different

28
TEST STATISTIC

29
EXAMPLE USING SPSS Analyze > Survival > Kaplan Meier Time: dur Status: status(1) – Here define 1 since it the value indicating event has occurred (i.e. death). Factor: Treat Options: Check off survival plot Click on Compare Factor and choose Log- Rank

30
OUTPUT

31

32

33
COX REGRESSION MODEL Incorporating Covariates

34
SURVIVAL MODELS Models that relate the time that passes before some event occurs to one or more covariates that may be associated with that amount of time.

35
COX REGRESSION MODEL This model produces a survival function that predicts the probability that an event has occurred at a given time t, for given predictor variables (covariates).

36
COX REGRESSION MODEL

37
HAZARD FUNCTION

38
INTERPRETATION OF THE BETAS

39
EXAMPLE USING SPSS

40
OUTPUT

41
Interpretation: The hazard for patients receiving treatment 2 is 28.8% of that for treatment 1 patients. Patients with normal renal function have 1.6% hazard as compared to those whose renal function is abnormal.

42
42

Similar presentations

© 2016 SlidePlayer.com Inc.

All rights reserved.

Ads by Google